|

Dual GIP/GLP-1 Receptor Agonist Tirzepatide Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Technical University of Munich1

Indications

Other1 trial

Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.